Dermatology Times February 2025 Print Recap

The February issue of Dermatology Times includes a collection of thought-provoking articles and topics ranging from the history and impact of Botox Cosmetic to a case presentation of trauma-induced melanocyte implantation leading to subcutaneous melanoma. Be sure to read the highlights from the issue below. Also, don’t miss a moment of Dermatology Times by signing up for our eNewsletters and subscribing to receive the free print issue and supplement each month.

Vitiligo, Melasma, PIH, and Albinism: Clinical Update and Emerging Therapies

Pigmentary disorders, though rarely life-threatening, pose a significant therapeutic challenge. The impact on patient quality of life and emotional well-being—often intensified by social stigmatization—underscores the need for improved treatment strategies. This review examines emerging therapies and their challenges for common pigmentary conditions, encompassing topical therapies, systemic agents, light-based modalities, lasers, and more.

Continue Reading from Rebecca Urbonas, Sumrah Jilani, and Bernard A. Cohen, MD

Botox Cosmetic: Ethics, Empowerment, and Innovation

“It’s not just the product. It’s the purpose of who we’re empowering, both the consumer and doctors,” said Mona Gohara, MD, board-certified dermatologist, consultant for Allergan Aesthetics, and associate clinical professor at Yale University in New Haven, Connecticut. Gohara sat down with Dermatology Times to highlight how Allergan Aesthetics’ science-driven approach, commitment to patient safety, and emphasis on inspiring women in medicine continues to shape the field of dermatology through Botox Cosmetic.

Continue Reading

Trauma-Induced Melanocyte Implantation Leading to Subcutaneous Melanoma

Melanoma is often challenging to diagnose when it lacks a visible primary cutaneous lesion. In such cases, melanoma of unknown primary (MUP) is often considered. MUP occurs when melanoma metastasizes to sites such as the subcutaneous tissue or lymph nodes without any obvious primary lesion on the skin. This diagnosis carries a favorable prognosis compared with cutaneous metastatic melanoma. This report presents a unique case of melanoma in a 66-year-old male patient, in which the melanoma developed subcutaneously after the traumatic removal of a preexisting epidermal nevus, which could initially suggest MUP but does not meet the criteria for this condition.

Continue Reading

Tips for Navigating AAD 2025

It is that time of year again: The largest dermatology meeting is at hand in Orlando, Florida next month. Yes, it’s almost time for the American Academy of Dermatology (AAD) annual meeting. This is the 83rd annual meeting, and it promises to be bigger and better than ever. There are almost 300 unique educational sessions for dermatology clinicians to choose from so they can learn, improve their clinical skills, and fulfill CME obligations. Last year, we blasted off to space with William Shatner; this year, I expect nothing short of magic.

In preparing for this year’s AAD, I reflected on my experiences at prior meetings. The first AAD meeting that I attended was in Miami, Florida, in 2010 (the 68th annual meeting). I was a first-year resident at Yale University and did not know what to expect. I remember being blown away by the massive size of the exhibit hall—and I still am today with the dragons, waterfalls, and many other amazing booths that are created for our entertainment. The show that the industry puts on in that exhibit hall is truly impressive.

Continue Reading from Editor In Chief, Christopher Bunick, MD, PhD

Click here to view all articles in the February issue